Isolation and characterization of diazoate intermediate upon nitrous acid and nitric oxide treatment of 2'-deoxycytidine.
The intermediate produced from dCyd by HNO2 and NO treatments was isolated and characterized. When 10 mM dCyd was treated with 100 mM NaNO2 in 1.0 M acetate buffer (pH 3.7) at 37 degrees C, a previously unidentified product was formed. By spectrometric measurements, the product was identified as a diazoate derivative of dCyd, 1-(beta-D-2'-deoxyribofuranosyl)-2-oxopyrimidine-4-diazoate. The time course of the concentration change of the diazoate showed a profile characteristic of a reaction intermediate, and the maximum yield was 37 microM at the reaction time of 25 min. Up to the reaction time of 10 min, the diazoate concentration was greater than that of dUrd, a deamination product of dCyd. Addition of thiocyanate increased the yield of the diazoate in HNO2 treatment, whereas addition of ascorbate decreased the yield. When 10 mM dCyd in 100 mM phosphate buffer was treated with NO at 37 degrees C under aerobic conditions holding the pH (7.2-7.6), the diazoate was also generated. The yield of the diazoate was higher than that of dUrd up to 15 mmol of NO absorption. At pH 3.7 and 37 degrees C, the diazoate was converted to dUrd with the first-order rate constant k = 4.8 x 10(-)4 s-1 (t1/2 = 24 min). Under physiological conditions (pH 7.4, 37 degrees C), however, it was fairly stable (k = 5.8 x 10(-)7 s-1, t1/2 = 330 h). In both cases, the diazoate was converted to dUrd exclusively and no other intermediates were detected by HPLC analysis. Uracil-DNA glycosylase did not remove the diazoate residue from an oligodeoxynucleotide containing this damage, [d(T6DT5), D = the diazoate]. The Tm value of a duplex containing the diazoate, d(T6DT5).d(A5GA6), was much lower than that of a duplex containing a correct C:G base pair, d(T6CT5).d(A5GA6). These results show that the diazoate is generated as a stable intermediate in the reactions of dCyd with HNO2 and NO and that the major product is the diazoate but not dUrd in the initial stage of the reactions. Thus, once formed in vivo, the diazoate persists for long time in DNA and may act as a major cytotoxic and/or genotoxic lesion with biologically relevant doses of HNO2 and NO.
Suzuki
T
T
Institute of Advanced Energy, Kyoto University, Uji, Japan.
Nakamura
T
T
Yamada
M
M
Ide
H
H
Kanaori
K
K
Tajima
K
K
Morii
T
T
Makino
K
K
D045647:DNA Glycosylases; D003841:Deoxycytidine / Q000737:chemistry*; D003979:Diazonium Compounds / Q000737:chemistry* / Q000302:isolation & purification*; D004355:Drug Stability; D007700:Kinetics; D009153:Mutagens / Q000737:chemistry; D009699:N-Glycosyl Hydrolases / Q000737:chemistry; D009569:Nitric Oxide / Q000737:chemistry*; D009608:Nitrous Acid / Q000737:chemistry*; D019906:Nuclear Magnetic Resonance, Biomolecular; D009692:Nucleic Acid Heteroduplexes / Q000737:chemistry; D009694:Nucleic Acid Precursors / Q000737:chemistry / Q000302:isolation & purification; D011743:Pyrimidines / Q000302:isolation & purification*; D013379:Substrate Specificity; D051981:Uracil-DNA Glycosidase
C119435:2'-deoxyribofuranosyl-2-oxopyrimidine-4-diazoate; D003979:Diazonium Compounds; D009153:Mutagens; D009692:Nucleic Acid Heteroduplexes; D009694:Nucleic Acid Precursors; D011743:Pyrimidines; D003841:Deoxycytidine; D009569:Nitric Oxide; D045647:DNA Glycosylases; D009699:N-Glycosyl Hydrolases; D051981:Uracil-DNA Glycosidase; D009608:Nitrous Acid